OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
ORGP56

Organic Farma Zdrowia SA

Food Retail & DistributionVerified

Organic Farma Zdrowia SA maintains a debt-to-equity ratio of 1.46, indicating a moderate reliance on debt financing, while its current ratio of 1.04 suggests limited short-term liquidity cushion. The company’s free cash flow of PLN 1.02 million and operating cash flow of PLN 1.49 million reflect modest cash generation, but its negative net cash position after subtracting total debt highlights potential liquidity constraints. The company’s return on equity of 23.17% and return on assets of 3.96% indicate strong equity returns but weak asset efficiency, which may signal underutilized capital or high cost of capital. These metrics fall below the typical thresholds for the Food Retail & Distribution industry, where asset turnover and operational leverage are key drivers of profitability. Organic Farma Zdrowia SA operates 18 retail stores across major Polish cities, with no disclosed segmental revenue breakdown. Its geographic concentration in urban centers may expose it to localized demand shifts, though the company’s presence in multiple regional hubs suggests some diversification. The Green Way restaurant chain is a notable operational segment, though its contribution to total revenue is unspecified. The company’s revenue of PLN 134.43 million is supported by its retail and restaurant operations, but no growth trajectory is evident from the latest financials. The absence of revenue history for prior periods limits the ability to assess growth momentum. The risk assessment identifies medium liquidity risk and low dilution risk, with the key flag being negative net cash after debt. The company has not disclosed any dilutive events in recent filings, and its diluted shares outstanding match basic shares, indicating no near-term dilution pressure. Recent filings and transcripts are not provided in the input data, so no specific events can be cited. However, the company’s operational focus on organic food retailing in a competitive Polish market suggests exposure to pricing pressures and supply chain volatility.

30-day price · ORGP+0.10 (+1.1%)
Low$8.35High$11.40Close$9.00As of18 May, 00:00 UTC
Profile
CompanyOrganic Farma Zdrowia SA
TickerORGP.WA
SectorConsumer Non-Cyclicals
BusinessFood & Drug Retailing
Industry groupFood & Drug Retailing
IndustryFood Retail & Distribution
AI analysis

Business. Organic Farma Zdrowia SA operates as a retailer of organic food products in Poland, generating revenue through the sale of organic produce, dairy, meats, grains, and other food items, as well as through its Green Way restaurant chain.

Classification. Organic Farma Zdrowia SA is classified under the Consumer Non-Cyclicals economic sector, Food & Drug Retailing business sector, and Food Retail & Distribution industry, with a confidence level of 0.92.

Organic Farma Zdrowia SA maintains a debt-to-equity ratio of 1.46, indicating a moderate reliance on debt financing, while its current ratio of 1.04 suggests limited short-term liquidity cushion. The company’s free cash flow of PLN 1.02 million and operating cash flow of PLN 1.49 million reflect modest cash generation, but its negative net cash position after subtracting total debt highlights potential liquidity constraints. The company’s return on equity of 23.17% and return on assets of 3.96% indicate strong equity returns but weak asset efficiency, which may signal underutilized capital or high cost of capital. These metrics fall below the typical thresholds for the Food Retail & Distribution industry, where asset turnover and operational leverage are key drivers of profitability. Organic Farma Zdrowia SA operates 18 retail stores across major Polish cities, with no disclosed segmental revenue breakdown. Its geographic concentration in urban centers may expose it to localized demand shifts, though the company’s presence in multiple regional hubs suggests some diversification. The Green Way restaurant chain is a notable operational segment, though its contribution to total revenue is unspecified. The company’s revenue of PLN 134.43 million is supported by its retail and restaurant operations, but no growth trajectory is evident from the latest financials. The absence of revenue history for prior periods limits the ability to assess growth momentum. The risk assessment identifies medium liquidity risk and low dilution risk, with the key flag being negative net cash after debt. The company has not disclosed any dilutive events in recent filings, and its diluted shares outstanding match basic shares, indicating no near-term dilution pressure. Recent filings and transcripts are not provided in the input data, so no specific events can be cited. However, the company’s operational focus on organic food retailing in a competitive Polish market suggests exposure to pricing pressures and supply chain volatility.
Key takeaways
  • Organic Farma Zdrowia SA generates modest cash flow but faces liquidity constraints due to a negative net cash position after debt.
  • The company’s return on equity is strong, but return on assets is weak, indicating underutilized capital or high financing costs.
  • Geographic concentration in urban Polish centers may limit diversification benefits.
  • No dilution risk is currently present, and the company’s share count remains unchanged.
  • --
  • # RATIONALES
  • ```json
  • {
Financial snapshot
PeriodHA-latest
CurrencyPLN
Revenue$134.4M
Gross profit$48.8M
Operating income$2.6M
Net income$1.4M
R&D
SG&A
D&A
SBC
Operating cash flow$1.5M
CapEx-$2.3M
Free cash flow$1.0M
Total assets$35.6M
Total liabilities$29.5M
Total equity$6.1M
Cash & equivalents
Long-term debt$8.9M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$6.1M
Net cash-$8.9M
Current ratio1.0
Debt/Equity1.5
ROA4.0%
ROE23.2%
Cash conversion1.1%
CapEx/Revenue-1.7%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Food & Drug Retailing · cohort 234 companies
MetricORGPActivity
Op margin1.9%2.8% medp25 0.9% · p75 5.9%below median
Net margin1.0%1.8% medp25 0.3% · p75 3.6%below median
Gross margin36.3%24.1% medp25 13.8% · p75 31.4%top quartile
CapEx / revenue-1.7%-2.0% medp25 -3.8% · p75 -1.0%above median
Debt / equity146.0%56.0% medp25 14.0% · p75 113.8%top quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-04 22:19 UTC#40b01f5b
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 22:21 UTCJob: 7b587af9